CirChem AB Statistics
Total Valuation
CirChem AB has a market cap or net worth of EUR 3.41 million. The enterprise value is 2.98 million.
| Market Cap | 3.41M |
| Enterprise Value | 2.98M |
Important Dates
The last earnings date was Thursday, November 20, 2025.
| Earnings Date | Nov 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 40.21M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +17.12% |
| Shares Change (QoQ) | +19.11% |
| Owned by Insiders (%) | 1.87% |
| Owned by Institutions (%) | 6.83% |
| Float | 39.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.83 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.81 |
| EV / Sales | 1.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.61 |
Financial Position
The company has a current ratio of 1.97, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.97 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.70 |
| Interest Coverage | -7.06 |
Financial Efficiency
Return on equity (ROE) is -15.65% and return on invested capital (ROIC) is -7.38%.
| Return on Equity (ROE) | -15.65% |
| Return on Assets (ROA) | -5.85% |
| Return on Invested Capital (ROIC) | -7.38% |
| Return on Capital Employed (ROCE) | -10.48% |
| Revenue Per Employee | 155,297 |
| Profits Per Employee | -51,708 |
| Employee Count | 12 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 36.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.98% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -66.98% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.18 |
| Relative Strength Index (RSI) | 40.44 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CirChem AB had revenue of EUR 1.86 million and -620,493 in losses. Loss per share was -0.02.
| Revenue | 1.86M |
| Gross Profit | 221,152 |
| Operating Income | -548,856 |
| Pretax Income | -620,493 |
| Net Income | -620,493 |
| EBITDA | -468,626 |
| EBIT | -548,856 |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 1.23 million in cash and 802,027 in debt, giving a net cash position of 426,657.
| Cash & Cash Equivalents | 1.23M |
| Total Debt | 802,027 |
| Net Cash | 426,657 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.44M |
| Book Value Per Share | 0.11 |
| Working Capital | 700,089 |
Cash Flow
In the last 12 months, operating cash flow was -626,915 and capital expenditures -514,846, giving a free cash flow of -1.14 million.
| Operating Cash Flow | -626,915 |
| Capital Expenditures | -514,846 |
| Free Cash Flow | -1.14M |
| FCF Per Share | n/a |
Margins
Gross margin is 11.87%, with operating and profit margins of -29.45% and -33.30%.
| Gross Margin | 11.87% |
| Operating Margin | -29.45% |
| Pretax Margin | -33.30% |
| Profit Margin | -33.30% |
| EBITDA Margin | -25.15% |
| EBIT Margin | -29.45% |
| FCF Margin | n/a |
Dividends & Yields
CirChem AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.12% |
| Shareholder Yield | -17.12% |
| Earnings Yield | -18.18% |
| FCF Yield | -33.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CirChem AB has an Altman Z-Score of 3.12 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.12 |
| Piotroski F-Score | 1 |